메뉴 건너뛰기




Volumn 20, Issue 2, 2008, Pages 180-185

In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii

Author keywords

Acinetobacter baumannii; Gatifloxacin; Meropenem; Polymyxin B; Pseudomonas aeruginosa

Indexed keywords

GATIFLOXACIN; MEROPENEM; POLYMYXIN B;

EID: 44849142803     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.2.180     Document Type: Article
Times cited : (21)

References (22)
  • 1
    • 27544464928 scopus 로고    scopus 로고
    • Clinical impact and pathogenicity of Acinetobacter
    • Joli-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11:868-873.
    • (2005) Clin Microbiol Infect , vol.11 , pp. 868-873
    • Joli-Guillou, M.L.1
  • 2
    • 22544477125 scopus 로고    scopus 로고
    • Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting
    • Navon-Venezia S, Ben-Ami R, Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 2005; 18:306-313.
    • (2005) Curr Opin Infect Dis , vol.18 , pp. 306-313
    • Navon-Venezia, S.1    Ben-Ami, R.2    Carmeli, Y.3
  • 3
    • 4644288571 scopus 로고    scopus 로고
    • SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001
    • Sader HS, Jones RN, Gales AC et al. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis 2004; 8:25-79.
    • (2004) Braz J Infect Dis , vol.8 , pp. 25-79
    • Sader, H.S.1    Jones, R.N.2    Gales, A.C.3
  • 4
    • 4344713310 scopus 로고    scopus 로고
    • Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: Five year report of the SENTRY Antimicrobial Surveillance Program
    • Tognim MCB, Andrade SS, Silbert S, Gales AC, Jones RN, Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis 2004; 8:284-291.
    • (2004) Int J Infect Dis , vol.8 , pp. 284-291
    • Tognim, M.C.B.1    Andrade, S.S.2    Silbert, S.3    Gales, A.C.4    Jones, R.N.5    Sader, H.S.6
  • 5
    • 25144472273 scopus 로고    scopus 로고
    • The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
    • Thomson JM, Bonomo R. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril! Curr Opin Microbiol 2005; 8:518-524.
    • (2005) Curr Opin Microbiol , vol.8 , pp. 518-524
    • Thomson, J.M.1    Bonomo, R.2
  • 7
    • 17644389620 scopus 로고    scopus 로고
    • Colistin: The revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections
    • Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 2005; 40:1333-1341.
    • (2005) Clin Infect Dis , vol.40 , pp. 1333-1341
    • Falagas, M.E.1    Kasiakou, S.K.2
  • 8
    • 0034454247 scopus 로고    scopus 로고
    • Mechanisms of action and resistance of older and newer fluoroquinolones
    • Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis 2000; 31:S24-S28.
    • (2000) Clin Infect Dis , vol.31
    • Hooper, D.C.1
  • 9
    • 0030984308 scopus 로고    scopus 로고
    • Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations
    • Marques MB, Brookings ES, Moser SA, Sonke PB, Waites KB. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations. Antimicrob Agents Chemother 1997; 41:881-885.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 881-885
    • Marques, M.B.1    Brookings, E.S.2    Moser, S.A.3    Sonke, P.B.4    Waites, K.B.5
  • 10
    • 0032416554 scopus 로고    scopus 로고
    • Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii
    • Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, Pujol M, Gudiol F. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Agents Chemother 1998; 42:793-802.
    • (1998) J Antimicrob Agents Chemother , vol.42 , pp. 793-802
    • Corbella, X.1    Ariza, J.2    Ardanuy, C.3    Vuelta, M.4    Tubau, F.5    Sora, M.6    Pujol, M.7    Gudiol, F.8
  • 11
    • 17644393475 scopus 로고    scopus 로고
    • Comprehensive in vitro evaluation of cefepime combined with aztreonan or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp
    • Sader HS, Jones RN. Comprehensive in vitro evaluation of cefepime combined with aztreonan or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. Int J Antimicrob Agents 2005; 25:380-384.
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 380-384
    • Sader, H.S.1    Jones, R.N.2
  • 12
    • 33747608427 scopus 로고    scopus 로고
    • Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species
    • Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43:S95-S99.
    • (2006) Clin Infect Dis , vol.43
    • Rahal, J.J.1
  • 13
    • 0037512376 scopus 로고    scopus 로고
    • Methods for dilution antimicrobial tests for bacteria that grow aerobically
    • National Committee for Clinical Laboratory Standards, Wayne, PA: NCCLS;
    • National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: NCCLS; 2003.
    • (2003) Approved standard M7-A6
  • 14
    • 84872848836 scopus 로고    scopus 로고
    • Lorian V ed. Antibiotics in Laboratory Medicine. Baltimore, Williams & Wilkins
    • Eliopoulos, GM, Moellering Jr., RC. Antimicrobial Combinations. In: Lorian V ed. Antibiotics in Laboratory Medicine. Baltimore, Williams & Wilkins. 1996: 432-492.
    • (1996) Antimicrobial Combinations , pp. 432-492
    • Eliopoulos, G.M.1    Moellering Jr., R.C.2
  • 15
    • 3843060294 scopus 로고    scopus 로고
    • Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections
    • Tascini C, Gemignani G, Ferranti S, Tagliaferri E, Leonildi A, Lucarini A, Menichetti F. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J Chemother 2004; 16:282-287.
    • (2004) J Chemother , vol.16 , pp. 282-287
    • Tascini, C.1    Gemignani, G.2    Ferranti, S.3    Tagliaferri, E.4    Leonildi, A.5    Lucarini, A.6    Menichetti, F.7
  • 16
  • 17
    • 0030069091 scopus 로고    scopus 로고
    • Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
    • Cappelletti DM, Rybak MJ. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40:677-683.
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 677-683
    • Cappelletti, D.M.1    Rybak, M.J.2
  • 19
    • 1442349053 scopus 로고    scopus 로고
    • Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates
    • Jung R, Husain M, Choi MK, Fish DN. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 2004; 48:1055-1057.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 1055-1057
    • Jung, R.1    Husain, M.2    Choi, M.K.3    Fish, D.N.4
  • 20
    • 1442324767 scopus 로고    scopus 로고
    • In vitro double and triple synergistic activities of polymyxin B, imipenen, and rifampin against multidrug-resistant Acinetobacter baumannii
    • Yoon J, Urban C, Terzian C, Mariano N, Rahal JJ. In vitro double and triple synergistic activities of polymyxin B, imipenen, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2004; 48:753-757.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 753-757
    • Yoon, J.1    Urban, C.2    Terzian, C.3    Mariano, N.4    Rahal, J.J.5
  • 21
    • 0036498656 scopus 로고    scopus 로고
    • Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
    • Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34:634-640.
    • (2002) Clin Infect Dis , vol.34 , pp. 634-640
    • Livermore, D.M.1
  • 22
    • 0033802358 scopus 로고    scopus 로고
    • Evaluation of antibiotic synergy against Acinetobacter baumannii: A comparison with Etest, time-kill, and checkerboard methods
    • Bonapace RB, White RL, Friedrich LV, Bosso JA. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagn Microbiol Infect Dis 2000; 38:43-50.
    • (2000) Diagn Microbiol Infect Dis , vol.38 , pp. 43-50
    • Bonapace, R.B.1    White, R.L.2    Friedrich, L.V.3    Bosso, J.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.